Literature DB >> 8611423

High frequency of p53 gene mutations in primary breast cancers in Japanese women, a low-incidence population.

A Hartmann1, H Blaszyk, S Saitoh, K Tsushima, Y Tamura, J M Cunningham, R M McGovern, J J Schroeder, S S Sommer, J S Kovach.   

Abstract

The pattern of acquired mutations in the p53 tumour-suppressor gene is potentially useful for determining factors contributing to carcinogenesis in diverse populations differing in incidence and/or mortality from the disease. We previously reported differences in mutational patterns of the p53 gene in primary breast cancers from Midwest US Caucasian, African-American and Austrian women. Herein, we report 16 mutations in 27 primary breast cancers from Japanese women from Hirosaki, a population with a low incidence of breast cancer. The frequency of 59.3% of p53 mutations is the highest reported in breast cancers from a particular ethnic group thus far. A relatively high number of mutations (7/16) were heterozygous in at least some tumour cell clusters. Intergroup comparisons of the mutational pattern between this population and several other US, European and Japanese populations do not show any statistically significant differences. There were recurrent mutations at two sites, codon 273 (R --> H; three mutations), a common hotspot of mutations in breast and other cancers, and codon 183 (S --> Stop; two mutations), a very rare location for p53 mutations. These mutations were shown to be independent and presumably not in the germ line. The highest frequency of p53 mutations raises the possibility that p53 mutagenesis is a predominant factor for breast cancer development in this low-risk Japanese group, whereas in other cohorts different mechanisms are likely to account for the higher proportion of breast cancer. Further studies are needed to confirm the present observations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611423      PMCID: PMC2075825          DOI: 10.1038/bjc.1996.179

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  39 in total

1.  Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy.

Authors:  A R La Spada; E M Wilson; D B Lubahn; A E Harding; K H Fischbeck
Journal:  Nature       Date:  1991-07-04       Impact factor: 49.962

Review 2.  Molecular epidemiology and the genetics of environmental cancer.

Authors:  P G Shields; C C Harris
Journal:  JAMA       Date:  1991-08-07       Impact factor: 56.272

3.  From gene to carcinogen: a rapidly evolving field in molecular epidemiology.

Authors:  P A Jones; J D Buckley; B E Henderson; R K Ross; M C Pike
Journal:  Cancer Res       Date:  1991-07-01       Impact factor: 12.701

4.  BstNI/NciI polymorphism of the human p53 gene (TP53).

Authors:  P M Chumakov; J R Jenkins
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

5.  Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa.

Authors:  B Bressac; M Kew; J Wands; M Ozturk
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

6.  Rapid and efficient screening for p53 gene mutations by dideoxy fingerprinting.

Authors:  H Blaszyk; A Hartmann; J J Schroeder; R M McGovern; S S Sommer; J S Kovach
Journal:  Biotechniques       Date:  1995-02       Impact factor: 1.993

7.  Direct sequencing from touch preparations of human carcinomas: analysis of p53 mutations in breast carcinomas.

Authors:  J S Kovach; R M McGovern; J D Cassady; S K Swanson; L E Wold; B Vogelstein; S S Sommer
Journal:  J Natl Cancer Inst       Date:  1991-07-17       Impact factor: 13.506

8.  Identification of p53 gene mutations in bladder cancers and urine samples.

Authors:  D Sidransky; A Von Eschenbach; Y C Tsai; P Jones; I Summerhayes; F Marshall; M Paul; P Green; S R Hamilton; P Frost
Journal:  Science       Date:  1991-05-03       Impact factor: 47.728

9.  A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma.

Authors:  D E Brash; J A Rudolph; J A Simon; A Lin; G J McKenna; H P Baden; A J Halperin; J Pontén
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

10.  Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.

Authors:  I Chiba; T Takahashi; M M Nau; D D'Amico; D T Curiel; T Mitsudomi; D L Buchhagen; D Carbone; S Piantadosi; H Koga
Journal:  Oncogene       Date:  1990-10       Impact factor: 9.867

View more
  6 in total

1.  Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects.

Authors:  P Hainaut; T Soussi; B Shomer; M Hollstein; M Greenblatt; E Hovig; C C Harris; R Montesano
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

2.  HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer.

Authors:  Khawla Al-Kuraya; Hedvika Novotny; Prashant Bavi; Abdul K Siraj; Shahab Uddin; Adnan Ezzat; Nasser Al Sanea; Fouad Al-Dayel; Hadeel Al-Mana; Salwa S Sheikh; Martina Mirlacher; Coya Tapia; Ronald Simon; Guido Sauter; Luigi Terracciano; Luigi Tornillo
Journal:  J Clin Pathol       Date:  2006-08-01       Impact factor: 3.411

3.  Rethinking breast cancer risk and the environment: the case for the precautionary principle.

Authors:  D L Davis; D Axelrod; L Bailey; M Gaynor; A J Sasco
Journal:  Environ Health Perspect       Date:  1998-09       Impact factor: 9.031

4.  Transcriptomics profiling study of breast cancer from Kingdom of Saudi Arabia revealed altered expression of Adiponectin and Fatty Acid Binding Protein4: Is lipid metabolism associated with breast cancer?

Authors:  Adnan Merdad; Sajjad Karim; Hans-Juergen Schulten; Manikandan Jayapal; Ashraf Dallol; Abdelbaset Buhmeida; Fatima Al-Thubaity; Mamdooh A GariI; Adeel G A Chaudhary; Adel M Abuzenadah; Mohammed H Al-Qahtani
Journal:  BMC Genomics       Date:  2015-01-15       Impact factor: 3.969

5.  Low expression of leptin and its association with breast cancer: A transcriptomic study.

Authors:  Sajjad Karim; Adnan Merdad; Hans-Juergen Schulten; Manikandan Jayapal; Ashraf Dallol; Abdelbaset Buhmeida; Fatima Al-Thubaity; Zeenat Mirza; Mamdooh A Gari; Adeel G Chaudhary; Adel M Abuzenadah; Mohammed H Al-Qahtani
Journal:  Oncol Rep       Date:  2016-05-13       Impact factor: 3.906

6.  KRAS and TP53 mutations in colorectal carcinoma.

Authors:  Khawla S Al-Kuraya
Journal:  Saudi J Gastroenterol       Date:  2009 Oct-Dec       Impact factor: 2.485

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.